Aspira Pathlab & Diagnostics share news and announcements
BSE: 540788Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹123.45.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹130 Cr3,082nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 23 May 2026
- 10.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −3.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −4.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 23 May 2026
- 0.11
- Volume, BSEVolume. Shares traded on the last trading day.
- 352
Aspira Pathlab & Diagnostics share news and announcements
520 announcements, routine notices left out, newest first. Page 2 of 11.
Feb 2026
10 Feb · Results
6 Feb · Management
4 Feb · Board meeting
Meeting on 10 Feb 2026: quarterly results
Jan 2026
5 Jan · Announcement under Regulation 30 (LODR)-Demise
2 Jan · Announcement under Regulation 30 (LODR)-Demise
Nov 2025
4 Nov · Board meeting
Meeting on 12 Nov 2025: quarterly results
Oct 2025
13 Oct · Announcement under Regulation 30 (LODR)-Open Offer - Updates
6 Oct · Detailed Public Statement
Sep 2025
26 Sep · Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
26 Sep · Public Announcement - Open Offer
26 Sep · Meeting
4 Sep · Letters Dispatched To Non-Email Shareholders
Aug 2025
4 Aug · Board meeting
Meeting on 12 Aug 2025: quarterly results
Jul 2025
Jun 2025
2 Jun · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
May 2025
28 May · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
16 May · Board meeting
7 May · Board meeting
Meeting on 16 May 2025: audited results
Apr 2025
15 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2